June 10, 2022
PRD Therapeutics, a spinoff of Kitasato University launched last year, will conduct R&D of naturally derived novel lipid metabolism control agents, compounds linked to Nobel laureate Satoshi Omura, the startup said on June 8. A group of researchers at Kitasato...read more